Creating Effective and Safe TAC T Cell Therapies by Targeting Compartmentalized Surface Antigens in Solid Tumors

Time: 10:00 am
day: Day Two


• The TAC receptor co-opts the endogenous TCR for efficacious and safe T cell anti-tumor responses without MHC restriction
• Compartmentalized surface antigens add to the repertoire of novel tumor-selective targets
• Development status of TAC T cell products in the treatment of solid tumors